Spasticity in People With Multiple Sclerosis Clinical Trial
Official title:
A Phase II Proof of Concept (PoC), Double-Blind, Randomised, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VSN16R for the Treatment of Spasticity in Subjects With Multiple Sclerosis
Phase II a Proof of concept study in Multiple Sclerosis (MS) patients with spasticity.
Single dose escalation followed by multiple fixed dose administrations to assess short term safety and to determine whether spasticity improves. ;